0001140361-16-046816.txt : 20160106 0001140361-16-046816.hdr.sgml : 20160106 20160106102440 ACCESSION NUMBER: 0001140361-16-046816 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160104 FILED AS OF DATE: 20160106 DATE AS OF CHANGE: 20160106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Sue CENTRAL INDEX KEY: 0001403769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 161325617 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc1.xml FORM 4 X0306 4 2016-01-04 0 0001367644 Emergent BioSolutions Inc. EBS 0001403769 Bailey Sue 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2016-01-04 4 M 0 5760 11.67 A 34260 D Common Stock 2016-01-04 4 S 0 5760 38.97 D 28500 D Common Stock 2016-01-04 4 M 0 2880 16.13 A 31380 D Common Stock 2016-01-04 4 S 0 2880 38.77 D 28500 D Common Stock 2016-01-04 4 M 0 2880 22.02 A 31380 D Common Stock 2016-01-04 4 S 0 2880 38.46 D 28500 D Stock Option 11.67 2016-01-04 4 M 0 5760 0 D 2019-05-20 Common Stock 5760 2880 D Stock Option 16.13 2016-01-04 4 M 0 2880 0 D 2020-05-19 Common Stock 2880 2880 D Stock Option 22.02 2016-01-04 4 M 0 2880 0 D 2021-05-18 Common Stock 2880 4320 D Consists of an option granted under the company's stock incentive plan on May 21, 2009. Consists of an option granted under the company's stock incentive plan on May 20, 2010. Consists of an option granted under the company's stock incentive plan on May 19, 2011. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.58 to $39.16, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.11, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.27 to $38.68, inclusive. The option vested in three equal installments in May 2010, 2011 and 2012. The option vested in three equal installments in May 2011, 2012 and 2013. The option vested in three equal installments in May 2012, 2013 and 2014. /s/ Eric Burt, attorney-in-fact 2016-01-06